Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Sheppard

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Ophthalmology|December 3, 2013
Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 studyJohn D Sheppard, Gail L Torkildsen, John D Lonsdale, et al.
Cornea|July 26, 2013
Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical TrialJohn D Sheppard, Ruhi Singh, Andrew J McClellan, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|February 2, 2023
Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?John D Sheppard, Leslie E O'Dell, Paul M Karpecki, et al.
Cornea|September 4, 2021
A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE StudyJohn D Sheppard, David L Wirta, Eugene McLaurin, et al.
The Ocular Surface|November 26, 2018
Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: Results from two pivotal clinical trialsJohn D Sheppard, Gail L Torkildsen, Joel A Geffin, et al.
Current Eye Research|October 15, 2008
Comparison of topical and intravenous administration of WIN 55-212-2 in normotensive rabbitsSandeep S Samudre, Jennifer L Schneider, Matthew H Oltmanns, et al.
Ocular Immunology and Inflammation|March 14, 2012
Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) TrialH Nida Sen, Lea T Drye, Debra A Goldstein, et al.
Eye & Contact Lens|August 2, 2014
Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%John D Sheppard, Eric D Donnenfeld, Edward J Holland, et al.
Acta Ophthalmologica|March 22, 2021
Management of repository corticotropin injection therapy for non-infectious uveitis: a Delphi studyQuan Dong Nguyen, Stephen D Anesi, Saradha Chexal, et al.
Cornea|June 18, 2026
Comparing Global Operating Room Waste Generated From Cataract, Corneal, and Conjunctival SurgeriesAashri I Aggarwal, Maria A Henriquez, Enrica Sarnicola, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Ophthalmology|December 3, 2013
Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 studyJohn D Sheppard, Gail L Torkildsen, John D Lonsdale, et al.
Cornea|July 26, 2013
Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical TrialJohn D Sheppard, Ruhi Singh, Andrew J McClellan, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|February 2, 2023
Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?John D Sheppard, Leslie E O'Dell, Paul M Karpecki, et al.
Cornea|September 4, 2021
A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE StudyJohn D Sheppard, David L Wirta, Eugene McLaurin, et al.
The Ocular Surface|November 26, 2018
Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: Results from two pivotal clinical trialsJohn D Sheppard, Gail L Torkildsen, Joel A Geffin, et al.
Current Eye Research|October 15, 2008
Comparison of topical and intravenous administration of WIN 55-212-2 in normotensive rabbitsSandeep S Samudre, Jennifer L Schneider, Matthew H Oltmanns, et al.
Ocular Immunology and Inflammation|March 14, 2012
Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) TrialH Nida Sen, Lea T Drye, Debra A Goldstein, et al.
Eye & Contact Lens|August 2, 2014
Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%John D Sheppard, Eric D Donnenfeld, Edward J Holland, et al.
Acta Ophthalmologica|March 22, 2021
Management of repository corticotropin injection therapy for non-infectious uveitis: a Delphi studyQuan Dong Nguyen, Stephen D Anesi, Saradha Chexal, et al.
Cornea|June 18, 2026
Comparing Global Operating Room Waste Generated From Cataract, Corneal, and Conjunctival SurgeriesAashri I Aggarwal, Maria A Henriquez, Enrica Sarnicola, et al.
Pageof 6